|
Feb 18, 22:45
|
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 15:06
|
Hims And Hers Weighs Legal Risks Against Growth In Longevity Pivot
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 13:01
|
Do You Think Hims & Hers Health (HIMS) is Positioned for Long-Term Growth?
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 09:06
|
Hims & Hers Health: 5 Key Questions Ahead Of Critical Q4 Earnings
|
N/A |
—
|
—
|
No analysis
|
|
Feb 18, 06:16
|
Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 16:04
|
Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk
|
N/A |
—
|
—
|
No analysis
|
|
Feb 17, 13:00
|
Market Whales and Their Recent Bets on HIMS Options
|
N/A |
—
|
—
|
No analysis
|
|
Feb 16, 17:13
|
Novo Nordisk Patent Fight With Hims And Hers Puts Valuation In Focus
|
N/A |
—
|
—
|
No analysis
|
|
Feb 16, 16:19
|
Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Month’s 48% Selloff
|
N/A |
—
|
—
|
No analysis
|
|
Feb 16, 15:00
|
Analysts Estimate Hims & Hers Health, Inc. (HIMS) to Report a Decline in Earnings: What to Look Out for
|
N/A |
—
|
—
|
No analysis
|
|
Feb 14, 10:30
|
How Ozempic Brought a Napster Moment to Big Pharma
|
N/A |
—
|
✓
|
# HIMS News Report — 2026-02-14
## Overview
| Metric | Value |
|--------|-------|
| **Ticker** | HIMS |
| **Date** | 2026-02-14 |
| **Total Articles...
|
|
Feb 14, 03:21
|
Novo Nordisk Faces Dual FDA Scrutiny And Legal Fights Over Obesity Drugs
|
N/A |
—
|
—
|
No analysis
|
|
Feb 14, 00:26
|
Hims & Hers Health (HIMS) Is Down 29.2% After Semaglutide Lawsuit And DOJ Referral - Has The Bull Case Changed?
|
N/A |
—
|
—
|
No analysis
|
|
Feb 13, 20:50
|
Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know
|
N/A |
—
|
—
|
No analysis
|
|
Feb 13, 19:08
|
Hims & Hers Falls Over 50% as Novo Files Obesity Lawsuit
|
N/A |
—
|
—
|
No analysis
|
|
Feb 13, 13:23
|
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows
|
N/A |
—
|
—
|
No analysis
|
|
Feb 13, 11:21
|
Analysis-US could take action including fines against Hims after brief Wegovy copy launch
|
N/A |
—
|
—
|
No analysis
|
|
Feb 13, 03:13
|
Novo Nordisk’s Legal Offensive On Compounded Obesity Drugs And Investor Implications
|
N/A |
—
|
—
|
No analysis
|
|
Feb 12, 16:20
|
Mixed options sentiment in Hims and Hers Health with shares down 2.18%
|
N/A |
—
|
—
|
No analysis
|
|
Feb 12, 14:59
|
Hims & Hers Strengthens Integrated Personalized Digital Care Platform
|
N/A |
—
|
—
|
No analysis
|
|
Feb 12, 14:02
|
Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market
|
N/A |
—
|
—
|
No analysis
|